TI
AXSM icon

Tidal Investments’s Axsome Therapeutics AXSM Stock Holding History

Tidal Investments’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$623K Sell
3,685
-834
-18% -$144K ﹤0.01% 1726
2025
Q4 		$825K Buy
4,519
+498
+12% +$69.5K ﹤0.01% 1378
2025
Q3 		$488K Sell
4,021
-204
-5% -$23K ﹤0.01% 1584
2025
Q2 		$441K Buy
+4,225
New +$447K ﹤0.01% 1485

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tidal Investments's AXSM Position: Q1 2026 in Review

Tidal Investments reduced its Axsome Therapeutics (AXSM) stake by 18% in Q1 2026, selling an estimated $144K and leaving 3,685 shares worth $623K. The position accounts for ﹤0.01% of the portfolio, ranked #1726.

Tidal Investments first reported a position in AXSM in Q2 2025 and has held it in 4 quarters since. The position peaked at $825K in Q4 2025. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Tidal Investments held 3,685 shares of Axsome Therapeutics worth $623K as of Q1 2026.
  • Tidal Investments sold 834 Axsome Therapeutics shares in Q1 2026, an estimated $144K.
  • Axsome Therapeutics made up ﹤0.01% of Tidal Investments's portfolio in Q1 2026, its #1726 holding.
  • Tidal Investments first reported a position in Axsome Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Tidal Investments's Axsome Therapeutics position peaked at $825K in Q4 2025.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Tidal Investments's 13F filing for Q1 2026, filed 15 May 2026.